THERAGENICS CORP (TGX) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 385 transactions totaling $3.0M, demonstrating a bearish sentiment with -$2.4M in net insider flow. The most recent transaction on Oct 29, 2013 involved a transaction of 128,424 shares valued at $282.5K.
No significant insider buying has been recorded for TGX in the recent period.
No significant insider selling has been recorded for TGX in the recent period.
Based on recent SEC filings, insider sentiment for TGX is bearish with an Insider Alignment Score of 11/100 and a net flow of -$2.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at THERAGENICS CORP (TGX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading TGX stock, having executed 385 transactions in the past 90 days. The most active insider is Patrick Ferguson (Executive), who has made 235 transactions totaling $2.8M.
Get notified when executives and directors at TGX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 29, 2013 | Herndon John V | Executive | Disposition | 128,424 | $2.20 | $282.5K | |
| Oct 29, 2013 | Dahlberg Kathleen | Executive | Disposition | 90,000 | $2.20 | $198.0K | |
| Oct 29, 2013 | Wyatt Engwall K. | Executive | Disposition | 209,550 | $2.20 | $461.0K | |
| Oct 29, 2013 | D. Moody Charles Jr | Executive | Disposition | 117,318 | $2.20 | $258.1K | |
| Oct 29, 2013 | A. A. Saunders Peter | Executive | Disposition | 139,000 | $2.20 | $305.8K | |
| Oct 29, 2013 | Christine Jacobs M. | Executive | Disposition | 946,523 | $2.20 | $2.1M | Large |
| Oct 29, 2013 | W. Smith Bruce | Executive | Disposition | 532,798 | $2.20 | $1.2M | Large |
| Oct 29, 2013 | J. Tarallo Francis | Executive | Disposition | 301,308 | $2.20 | $662.9K | Large |
| Oct 29, 2013 | J. Tarallo Francis | Executive | Disposition | 136,364 | $2.20 | $300.0K | |
| Oct 29, 2013 | Zeman Janet | Executive | Disposition | 235,962 | $2.20 | $519.1K | Large |
| Oct 29, 2013 | Plante Joseph | Executive | Disposition | 219,175 | $2.20 | $482.2K | |
| Oct 29, 2013 | Plante Joseph | Executive | Disposition | 54,308 | $2.20 | $119.5K | |
| Oct 29, 2013 | Russell Small C. | Executive | Disposition | 230,250 | $2.20 | $506.6K | Large |
| Oct 29, 2013 | Russell Small C. | Executive | Disposition | 68,162 | $2.20 | $150.0K | |
| Oct 26, 2013 | Zeman Janet | Executive | Disposition | 68,182 | $2.20 | $150.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Disposition(D) | 20 | $7.7M | 58.1% |
Sale(S) | 229 | $2.7M | 20.5% |
Award(A) | 110 | $2.2M | 17.1% |
Purchase(P) | 15 | $341.7K | 2.6% |
Other(J) | 3 | $205.5K | 1.6% |
Payment(F) | 8 | $22.9K | 0.2% |
Insider selling pressure at THERAGENICS CORP has increased, with 22 insiders executing 385 transactions across all time. Total sales of $2.7M significantly outpace purchases of $341.7K, resulting in a net outflow of $2.4M. This selling activity appears largely discretionary, which may warrant closer attention from investors.